Veradigm Inc. (NASDAQ:MDRX – Get Free Report)’s share price gapped up prior to trading on Tuesday . The stock had previously closed at $9.76, but opened at $10.10. Veradigm shares last traded at $9.75, with a volume of 4,649 shares changing hands.
Analyst Upgrades and Downgrades
Separately, StockNews.com initiated coverage on shares of Veradigm in a research report on Wednesday, December 11th. They issued a “hold” rating on the stock. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, Veradigm currently has an average rating of “Hold” and a consensus price target of $11.75.
Read Our Latest Stock Report on MDRX
Veradigm Stock Performance
Institutional Investors Weigh In On Veradigm
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC bought a new position in shares of Veradigm Inc. (NASDAQ:MDRX – Free Report) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 3,974 shares of the software maker’s stock, valued at approximately $38,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- Breakout Stocks: What They Are and How to Identify Them
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- Business Services Stocks Investing
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- When to Sell a Stock for Profit or Loss
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.